Rheumatoid arthritis and spondyloarthropathy by Vassallo, Pierre
Rheumatoid arthritis (RA) and spondyloarthropathy are two 
groups of inflammatory joint disease. 
Detection of early inflammatory joint 
disease is not possible with clinical 
examination or plain radiography, which 
have been the main diagnostic methods 
in the past. Changes detected on 
plain radiography are those of chronic 
damage caused by these conditions 
rather that acute inflammation, which 
results in delay in diagnosis and often 
suboptimal outcomes in these patients. 
RA is the most common 
inflammatory arthritis, affecting 
approximately 1% of the world’s 
population. In 25% of cases, 
non-articular soft tissues are also 
involved in the inflammatory process. 
RA results from  inflammation of 
the synovial membrane (synovitis), 
with joints becoming swollen, tender 
and warm and stiff. Most commonly 
involved are the small joints of 
the hands, feet and cervical spine, 
but larger joints like the shoulder and 
knee may be affected. Multiple joint 
involvment (polyarthritis) is common and 
is typically symmetrical in distribution 
although not in early disease. Over 
the last two decades, significant 
improvement in its prognosis has been 
achieved owing to new strategies for 
disease management, the emergence of 
new biologic therapies (including tumor 
necrosis factor–blocking agents such as 
rituximab, abatacept, and tocilizumab) 
and better utilization of the conventional 
disease-modifying antirheumatic 
drugs. Furthermore the generalized 
use of standardized criteria for the 
evaluation of disease activity such as 
the American College of Rheumatology 
(ACR) improvement criteria and 
European League Against Rheumatism 
response criteria have proved useful for 
monitoring the disease course in daily 
clinical practice.
In contrast, spondyloarthropathy 
comprises a group of chronic 
inflammatory rheumatic diseases, 
including ankylosing spondylitis, 
reactive arthritis (Reiter syndrome), 
arthritis or spondylitis associated 
with inflammatory bowel disease, 
and psoriatic arthritis, as well as 
undifferentiated spondyloarthritis. 
These afflictions predominantly 
affect the axial skeleton, causing 
pain and stiffness; are seronegative 
for rheumatoid factor; and are often 
associated with the presence of 
human lymphocyte antigen (HLA)–
B27. They are largely differentiated 
on the basis of clinical information 
and the distribution of radiographic 
abnormalities. Spondylarthropathy 
tends to have an asymmetric 
distribution when multiple joints are 
affected.
MR imaging has demonstrated 
greater sensitivity for the detection 
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of synovitis and erosions than either 
clinical examination or conventional 
radiography and can help establish 
an early diagnosis of RA and 
spondyloarthropathy. It also allows the 
detection of bone marrow oedema, 
which is thought to be a precursor 
for the development of erosions in 
early RA and spondyloarthropathy as 
well as a marker of active inflammation. 
In addition, MR imaging can 
help differentiate RA from some 
clinical subsets of peripheral 
spondyloarthropathies by allowing 
identification of inflammation at the 
insertions of ligaments and tendons 
(enthesitis).
Magnetic resonance (MR) imaging 
has become the most recent innovation 
and the important change with 
respect to the previously established 
classification criteria. MR imaging can 
serve as a biomarker of disease activity, 
allows monitoring, and can provide 
guidance for the treatment of affected 
patients, and has become even more 
central to the care of these patients. 
Familiarity with the anatomy, anatomic 
variants, and physiologic joint changes 
is important for correctly interpreting 
findings and avoiding misdiagnosis.
The term early RA is not defined 
precisely in the literature. Most authors 
use the term to describe only disease 
duration of less than 1 year from the 
first episode of clinically detectable 
joint inflammation, although the 
duration of early RA varies widely 
between publications (up to 2–3 years 
in some series). Erosions, periarticular 
osteopenia, and cartilage loss are all 
known to occur within 2 years of the 
onset of RA in the absence of effective 
therapy. Radiography is not helpful 
for establishing an early diagnosis 
of RA, since fewer than 20–25% of 
patients initially present with erosions. 
Up to 30% of patients test negative 
for serum rheumatoid factor, and 
other pathognomonic features such 
as rheumatoid nodules usually appear 
late in the disease process. In addition, 
RA may start in atypical fashion. It can 
have a very sudden onset with marked 
systemic features such as fatigue, 
fever, and weight loss, or can manifest 
as polymyalgia rheumatica syndrome 
Figure 1: Synovitis in early RA of the wrist (6 months duration); patient had normal 
radiographic findings. (A) Coronal T1-w MR image shows extensive synovitis 
(arrows). On STIR (B) and axial fat saturated T2-w (c) MR images, the synovitis has 
high signal intensity (arrows). * indicate bone marrow oedema at the bases of the 
second metacarpal, capitate, and hamate bones. (d) Sagittal contrast-enhanced 
fat-saturated T1-w MR image shows intense enhancement of the periscaphoid 
synovitis (arrows), in the area of bone marrow oedema in the scaphoid bone and in 
the base of the second metacarpal bone (*).
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(pain and morning stiffness in the hip 
and shoulder girdles), oligo- or even 
mono-arthritis, or bilateral carpal tunnel 
syndrome. The extent of irreversible 
joint damage and disability will depend 
primarily on how much time has 
elapsed before satisfactory treatment 
is achieved. The effectiveness of 
management strategies designed to 
disrupt the development of RA and 
prevent the long-term effects of this 
disease depends largely on early 
initiation of treatment.
When imaging for RA, the hands 
are the most likely to be involved and 
usually symmetrically. However it is 
best to image the more painful hand 
since this is likely to produce more 
florid findings. Imaging should include 
coronal and axial T1-weighted, STIR or 
fat-saturated T2-weighted images and 
pre- and post IV contrast (Gadolinium 
DTPA) Fat-Saturated T1-weighted 
images using a high resolution flexible 
coil and covering all the wrist joints as 
well as the MCP and PIP joints since 
this is the most common pattern of 
distribution in RA. 
Synovitis is the earliest abnormality 
to appear in RA. Normal synovial 
tissue that lines joint cavities, bursae, 
and tendinous sheaths is usually too 
thin to be visible on MR images. MR 
imaging signs of synovitis include 
synovial thickening, increased water 
content, contrast enhancement, 
or a combination thereof (Fig 1). 
Contrast enhanced T1-w MR images 
allow distinction between synovial 
hypertrophy and joint effusion. Fibrotic 
pannus, which is usually present in 
end-stage rheumatoid arthritis, may 
show poor or limited enhancement 
after the intravenous administration of 
gadolinium-based contrast material.  
(to be continued)
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